Graviton Bio Science announced it raised $39.8 Million in an initial filing from an offering of $50 Million

Dec 04, 2023•over 1 year ago

Amount Raised

$39.8 Million

New YorkBiotechnology

Company Information

Company

Graviton BioScience

Location

125 WEST END AVE.

New York, New York, United States

About

Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds.

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Graviton Bio Science announced it raised $39.8 Million in an initial filing from an offering of $50 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information